Morning Market Losers

By: via Benzinga
Corcept Therapeutics (NASDAQ: CORT) declined 50.50% to $1.99 following earnings miss and drug trial halt. Oclaro (NASDAQ: OCLR) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.